Industry Research Reports
Home > Reports > Consumer Goods > Low-concentration Atropine Eye Drops- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Low-concentration Atropine Eye Drops- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Industry: Consumer Goods
Published Date: 2024-04-28
Pages: 89 Pages
Report ld: 3129092
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Atropine eye drops have been shown safe to use in children when used as prescribed. While atropine has potential for causing toxic effects if taken by mouth, it is greatly diluted when formulated into eye drops. Medication safety is very important - if a young child accidentally swallows a bottle of atropine eye drops this can have very serious side effects.
The low concentrations of atropine used in myopia management have far less side effects for long term use, and have proven to be safe and effective for slowing myopia progression in children from age 4 to 14 at the start of treatment, and for up to two to three years.Amongst these lower concentrations, atropine 0.05% currently appears to be the most effective, with minimal side effects.
The global market for Low-concentration Atropine Eye Drops was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.
North American market for Low-concentration Atropine Eye Drops was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Low-concentration Atropine Eye Drops was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Low-concentration Atropine Eye Drops was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Low-concentration Atropine Eye Drops include Aspen, ENTOD Pharmaceuticals, Santen Pharmaceutical, Shenyang Xingqi Pharmaceutical, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Low-concentration Atropine Eye Drops, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Low-concentration Atropine Eye Drops by region & country, by Type, and by Application.
The Low-concentration Atropine Eye Drops market size, estimations, and forecasts are provided in terms of sales volume (L) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Low-concentration Atropine Eye Drops.
MARKET SEGMENTATION
By Company
- Aspen
- ENTOD Pharmaceuticals
- Santen Pharmaceutical
- Shenyang Xingqi Pharmaceutical
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- 0.01%
- 0.025%
- 0.05%
Segment by Application
- Children
- Teenagers
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Low-concentration Atropine Eye Drops manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Low-concentration Atropine Eye Drops in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Low-concentration Atropine Eye Drops in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Low-concentration Atropine Eye Drops Product Introduction
1.2 Global Low-concentration Atropine Eye Drops Market Size Forecast
1.2.1 Global Low-concentration Atropine Eye Drops Sales Value (2019-2030)
1.2.2 Global Low-concentration Atropine Eye Drops Sales Volume (2019-2030)
1.2.3 Global Low-concentration Atropine Eye Drops Sales Price (2019-2030)
1.3 Low-concentration Atropine Eye Drops Market Trends & Drivers
1.3.1 Low-concentration Atropine Eye Drops Industry Trends
1.3.2 Low-concentration Atropine Eye Drops Market Drivers & Opportunity
1.3.3 Low-concentration Atropine Eye Drops Market Challenges
1.3.4 Low-concentration Atropine Eye Drops Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Low-concentration Atropine Eye Drops Players Revenue Ranking (2023)
2.2 Global Low-concentration Atropine Eye Drops Revenue by Company (2019-2024)
2.3 Global Low-concentration Atropine Eye Drops Players Sales Volume Ranking (2023)
2.4 Global Low-concentration Atropine Eye Drops Sales Volume by Company Players (2019-2024)
2.5 Global Low-concentration Atropine Eye Drops Average Price by Company (2019-2024)
2.6 Key Manufacturers Low-concentration Atropine Eye Drops Manufacturing Base and Headquarters
2.7 Key Manufacturers Low-concentration Atropine Eye Drops Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Low-concentration Atropine Eye Drops
2.9 Low-concentration Atropine Eye Drops Market Competitive Analysis
2.9.1 Low-concentration Atropine Eye Drops Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Low-concentration Atropine Eye Drops Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Low-concentration Atropine Eye Drops as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 0.01%
3.1.2 0.025%
3.1.3 0.05%
3.2 Global Low-concentration Atropine Eye Drops Sales Value by Type
3.2.1 Global Low-concentration Atropine Eye Drops Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Low-concentration Atropine Eye Drops Sales Value, by Type (2019-2030)
3.2.3 Global Low-concentration Atropine Eye Drops Sales Value, by Type (%) (2019-2030)
3.3 Global Low-concentration Atropine Eye Drops Sales Volume by Type
3.3.1 Global Low-concentration Atropine Eye Drops Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Low-concentration Atropine Eye Drops Sales Volume, by Type (2019-2030)
3.3.3 Global Low-concentration Atropine Eye Drops Sales Volume, by Type (%) (2019-2030)
3.4 Global Low-concentration Atropine Eye Drops Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Children
4.1.2 Teenagers
4.2 Global Low-concentration Atropine Eye Drops Sales Value by Application
4.2.1 Global Low-concentration Atropine Eye Drops Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Low-concentration Atropine Eye Drops Sales Value, by Application (2019-2030)
4.2.3 Global Low-concentration Atropine Eye Drops Sales Value, by Application (%) (2019-2030)
4.3 Global Low-concentration Atropine Eye Drops Sales Volume by Application
4.3.1 Global Low-concentration Atropine Eye Drops Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Low-concentration Atropine Eye Drops Sales Volume, by Application (2019-2030)
4.3.3 Global Low-concentration Atropine Eye Drops Sales Volume, by Application (%) (2019-2030)
4.4 Global Low-concentration Atropine Eye Drops Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Low-concentration Atropine Eye Drops Sales Value by Region
5.1.1 Global Low-concentration Atropine Eye Drops Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Low-concentration Atropine Eye Drops Sales Value by Region (2019-2024)
5.1.3 Global Low-concentration Atropine Eye Drops Sales Value by Region (2025-2030)
5.1.4 Global Low-concentration Atropine Eye Drops Sales Value by Region (%), (2019-2030)
5.2 Global Low-concentration Atropine Eye Drops Sales Volume by Region
5.2.1 Global Low-concentration Atropine Eye Drops Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Low-concentration Atropine Eye Drops Sales Volume by Region (2019-2024)
5.2.3 Global Low-concentration Atropine Eye Drops Sales Volume by Region (2025-2030)
5.2.4 Global Low-concentration Atropine Eye Drops Sales Volume by Region (%), (2019-2030)
5.3 Global Low-concentration Atropine Eye Drops Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Low-concentration Atropine Eye Drops Sales Value, 2019-2030
5.4.2 North America Low-concentration Atropine Eye Drops Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Low-concentration Atropine Eye Drops Sales Value, 2019-2030
5.5.2 Europe Low-concentration Atropine Eye Drops Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Low-concentration Atropine Eye Drops Sales Value, 2019-2030
5.6.2 Asia Pacific Low-concentration Atropine Eye Drops Sales Value by Region (%), 2023 VS 2030
5.7 South America
5.7.1 South America Low-concentration Atropine Eye Drops Sales Value, 2019-2030
5.7.2 South America Low-concentration Atropine Eye Drops Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Low-concentration Atropine Eye Drops Sales Value, 2019-2030
5.8.2 Middle East & Africa Low-concentration Atropine Eye Drops Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Low-concentration Atropine Eye Drops Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Low-concentration Atropine Eye Drops Sales Value
6.2.1 Key Countries/Regions Low-concentration Atropine Eye Drops Sales Value, 2019-2030
6.2.2 Key Countries/Regions Low-concentration Atropine Eye Drops Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Low-concentration Atropine Eye Drops Sales Value, 2019-2030
6.3.2 United States Low-concentration Atropine Eye Drops Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Low-concentration Atropine Eye Drops Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Low-concentration Atropine Eye Drops Sales Value, 2019-2030
6.4.2 Europe Low-concentration Atropine Eye Drops Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Low-concentration Atropine Eye Drops Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Low-concentration Atropine Eye Drops Sales Value, 2019-2030
6.5.2 China Low-concentration Atropine Eye Drops Sales Value by Type (%), 2023 VS 2030
6.5.3 China Low-concentration Atropine Eye Drops Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Low-concentration Atropine Eye Drops Sales Value, 2019-2030
6.6.2 Japan Low-concentration Atropine Eye Drops Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Low-concentration Atropine Eye Drops Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Low-concentration Atropine Eye Drops Sales Value, 2019-2030
6.7.2 South Korea Low-concentration Atropine Eye Drops Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Low-concentration Atropine Eye Drops Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Low-concentration Atropine Eye Drops Sales Value, 2019-2030
6.8.2 Southeast Asia Low-concentration Atropine Eye Drops Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Low-concentration Atropine Eye Drops Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Low-concentration Atropine Eye Drops Sales Value, 2019-2030
6.9.2 India Low-concentration Atropine Eye Drops Sales Value by Type (%), 2023 VS 2030
6.9.3 India Low-concentration Atropine Eye Drops Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Aspen
7.1.1 Aspen Company Information
7.1.2 Aspen Introduction and Business Overview
7.1.3 Aspen Low-concentration Atropine Eye Drops Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Aspen Low-concentration Atropine Eye Drops Product Offerings
7.1.5 Aspen Recent Development
7.2 ENTOD Pharmaceuticals
7.2.1 ENTOD Pharmaceuticals Company Information
7.2.2 ENTOD Pharmaceuticals Introduction and Business Overview
7.2.3 ENTOD Pharmaceuticals Low-concentration Atropine Eye Drops Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 ENTOD Pharmaceuticals Low-concentration Atropine Eye Drops Product Offerings
7.2.5 ENTOD Pharmaceuticals Recent Development
7.3 Santen Pharmaceutical
7.3.1 Santen Pharmaceutical Company Information
7.3.2 Santen Pharmaceutical Introduction and Business Overview
7.3.3 Santen Pharmaceutical Low-concentration Atropine Eye Drops Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Santen Pharmaceutical Low-concentration Atropine Eye Drops Product Offerings
7.3.5 Santen Pharmaceutical Recent Development
7.4 Shenyang Xingqi Pharmaceutical
7.4.1 Shenyang Xingqi Pharmaceutical Company Information
7.4.2 Shenyang Xingqi Pharmaceutical Introduction and Business Overview
7.4.3 Shenyang Xingqi Pharmaceutical Low-concentration Atropine Eye Drops Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Shenyang Xingqi Pharmaceutical Low-concentration Atropine Eye Drops Product Offerings
7.4.5 Shenyang Xingqi Pharmaceutical Recent Development
8 Industry Chain Analysis
8.1 Low-concentration Atropine Eye Drops Industrial Chain
8.2 Low-concentration Atropine Eye Drops Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Low-concentration Atropine Eye Drops Sales Model
8.5.2 Sales Channel
8.5.3 Low-concentration Atropine Eye Drops Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Low-concentration Atropine Eye Drops Market Trends
Table 2. Low-concentration Atropine Eye Drops Market Drivers & Opportunity
Table 3. Low-concentration Atropine Eye Drops Market Challenges
Table 4. Low-concentration Atropine Eye Drops Market Restraints
Table 5. Global Low-concentration Atropine Eye Drops Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Low-concentration Atropine Eye Drops Revenue Market Share by Company (2019-2024)
Table 7. Global Low-concentration Atropine Eye Drops Sales Volume by Company (2019-2024) & (L)
Table 8. Global Low-concentration Atropine Eye Drops Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Low-concentration Atropine Eye Drops Price by Company (2019-2024) & (US$/ml)
Table 10. Key Manufacturers Low-concentration Atropine Eye Drops Manufacturing Base and Headquarters
Table 11. Key Manufacturers Low-concentration Atropine Eye Drops Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Low-concentration Atropine Eye Drops
Table 13. Global Low-concentration Atropine Eye Drops Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Low-concentration Atropine Eye Drops as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Low-concentration Atropine Eye Drops Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Low-concentration Atropine Eye Drops Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Low-concentration Atropine Eye Drops Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Low-concentration Atropine Eye Drops Sales Market Share in Value by Type (2019-2024)
Table 20. Global Low-concentration Atropine Eye Drops Sales Market Share in Value by Type (2025-2030)
Table 21. Global Low-concentration Atropine Eye Drops Sales Volume by Type: 2019 VS 2023 VS 2030 (L)
Table 22. Global Low-concentration Atropine Eye Drops Sales Volume by Type (2019-2024) & (L)
Table 23. Global Low-concentration Atropine Eye Drops Sales Volume by Type (2025-2030) & (L)
Table 24. Global Low-concentration Atropine Eye Drops Sales Market Share in Volume by Type (2019-2024)
Table 25. Global Low-concentration Atropine Eye Drops Sales Market Share in Volume by Type (2025-2030)
Table 26. Global Low-concentration Atropine Eye Drops Price by Type (2019-2024) & (US$/ml)
Table 27. Global Low-concentration Atropine Eye Drops Price by Type (2025-2030) & (US$/ml)
Table 28. Global Low-concentration Atropine Eye Drops Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Low-concentration Atropine Eye Drops Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Low-concentration Atropine Eye Drops Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Low-concentration Atropine Eye Drops Sales Market Share in Value by Application (2019-2024)
Table 32. Global Low-concentration Atropine Eye Drops Sales Market Share in Value by Application (2025-2030)
Table 33. Global Low-concentration Atropine Eye Drops Sales Volume by Application: 2019 VS 2023 VS 2030 (L)
Table 34. Global Low-concentration Atropine Eye Drops Sales Volume by Application (2019-2024) & (L)
Table 35. Global Low-concentration Atropine Eye Drops Sales Volume by Application (2025-2030) & (L)
Table 36. Global Low-concentration Atropine Eye Drops Sales Market Share in Volume by Application (2019-2024)
Table 37. Global Low-concentration Atropine Eye Drops Sales Market Share in Volume by Application (2025-2030)
Table 38. Global Low-concentration Atropine Eye Drops Price by Application (2019-2024) & (US$/ml)
Table 39. Global Low-concentration Atropine Eye Drops Price by Application (2025-2030) & (US$/ml)
Table 40. Global Low-concentration Atropine Eye Drops Sales Value by Region, (2019 VS 2023 VS 2030) & (US$ Million)
Table 41. Global Low-concentration Atropine Eye Drops Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Low-concentration Atropine Eye Drops Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Low-concentration Atropine Eye Drops Sales Value by Region (2019-2024) & (%)
Table 44. Global Low-concentration Atropine Eye Drops Sales Value by Region (2025-2030) & (%)
Table 45. Global Low-concentration Atropine Eye Drops Sales Volume by Region (L): 2019 VS 2023 VS 2030
Table 46. Global Low-concentration Atropine Eye Drops Sales Volume by Region (2019-2024) & (L)
Table 47. Global Low-concentration Atropine Eye Drops Sales Volume by Region (2025-2030) & (L)
Table 48. Global Low-concentration Atropine Eye Drops Sales Volume by Region (2019-2024) & (%)
Table 49. Global Low-concentration Atropine Eye Drops Sales Volume by Region (2025-2030) & (%)
Table 50. Global Low-concentration Atropine Eye Drops Average Price by Region (2019-2024) & (US$/ml)
Table 51. Global Low-concentration Atropine Eye Drops Average Price by Region (2025-2030) & (US$/ml)
Table 52. Key Countries/Regions Low-concentration Atropine Eye Drops Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Low-concentration Atropine Eye Drops Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Low-concentration Atropine Eye Drops Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Low-concentration Atropine Eye Drops Sales Volume, (2019-2024) & (L)
Table 56. Key Countries/Regions Low-concentration Atropine Eye Drops Sales Volume, (2025-2030) & (L)
Table 57. Aspen Company Information
Table 58. Aspen Introduction and Business Overview
Table 59. Aspen Low-concentration Atropine Eye Drops Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2019-2024)
Table 60. Aspen Low-concentration Atropine Eye Drops Product Offerings
Table 61. Aspen Recent Development
Table 62. ENTOD Pharmaceuticals Company Information
Table 63. ENTOD Pharmaceuticals Introduction and Business Overview
Table 64. ENTOD Pharmaceuticals Low-concentration Atropine Eye Drops Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2019-2024)
Table 65. ENTOD Pharmaceuticals Low-concentration Atropine Eye Drops Product Offerings
Table 66. ENTOD Pharmaceuticals Recent Development
Table 67. Santen Pharmaceutical Company Information
Table 68. Santen Pharmaceutical Introduction and Business Overview
Table 69. Santen Pharmaceutical Low-concentration Atropine Eye Drops Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2019-2024)
Table 70. Santen Pharmaceutical Low-concentration Atropine Eye Drops Product Offerings
Table 71. Santen Pharmaceutical Recent Development
Table 72. Shenyang Xingqi Pharmaceutical Company Information
Table 73. Shenyang Xingqi Pharmaceutical Introduction and Business Overview
Table 74. Shenyang Xingqi Pharmaceutical Low-concentration Atropine Eye Drops Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2019-2024)
Table 75. Shenyang Xingqi Pharmaceutical Low-concentration Atropine Eye Drops Product Offerings
Table 76. Shenyang Xingqi Pharmaceutical Recent Development
Table 77. Key Raw Materials Lists
Table 78. Raw Materials Key Suppliers Lists
Table 79. Low-concentration Atropine Eye Drops Downstream Customers
Table 80. Low-concentration Atropine Eye Drops Distributors List
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Low-concentration Atropine Eye Drops Product Picture
Figure 2. Global Low-concentration Atropine Eye Drops Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Low-concentration Atropine Eye Drops Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Low-concentration Atropine Eye Drops Sales Volume (2019-2030) & (L)
Figure 5. Global Low-concentration Atropine Eye Drops Sales Price (2019-2030) & (US$/ml)
Figure 6. Low-concentration Atropine Eye Drops Report Years Considered
Figure 7. Global Low-concentration Atropine Eye Drops Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Low-concentration Atropine Eye Drops Players Sales Volume Ranking (2023) & (US$ Million)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Low-concentration Atropine Eye Drops Revenue in 2023
Figure 10. Low-concentration Atropine Eye Drops Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. 0.01% Picture
Figure 12. 0.025% Picture
Figure 13. 0.05% Picture
Figure 14. Global Low-concentration Atropine Eye Drops Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Low-concentration Atropine Eye Drops Sales Value Market Share by Type, 2023 & 2030
Figure 16. Global Low-concentration Atropine Eye Drops Sales Volume by Type (2019 VS 2023 VS 2030) & (L)
Figure 17. Global Low-concentration Atropine Eye Drops Sales Volume Market Share by Type, 2023 & 2030
Figure 18. Global Low-concentration Atropine Eye Drops Price by Type (2019-2030) & (US$/ml)
Figure 19. Product Picture of Children
Figure 20. Product Picture of Teenagers
Figure 21. Global Low-concentration Atropine Eye Drops Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Low-concentration Atropine Eye Drops Sales Value Market Share by Application, 2023 & 2030
Figure 23. Global Low-concentration Atropine Eye Drops Sales Volume by Application (2019 VS 2023 VS 2030) & (L)
Figure 24. Global Low-concentration Atropine Eye Drops Sales Volume Market Share by Application, 2023 & 2030
Figure 25. Global Low-concentration Atropine Eye Drops Price by Application (2019-2030) & (US$/ml)
Figure 26. North America Low-concentration Atropine Eye Drops Sales Value (2019-2030) & (US$ Million)
Figure 27. North America Low-concentration Atropine Eye Drops Sales Value by Country (%), 2023 VS 2030
Figure 28. Europe Low-concentration Atropine Eye Drops Sales Value, (2019-2030) & (US$ Million)
Figure 29. Europe Low-concentration Atropine Eye Drops Sales Value by Country (%), 2023 VS 2030
Figure 30. Asia Pacific Low-concentration Atropine Eye Drops Sales Value, (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Low-concentration Atropine Eye Drops Sales Value by Region (%), 2023 VS 2030
Figure 32. South America Low-concentration Atropine Eye Drops Sales Value, (2019-2030) & (US$ Million)
Figure 33. South America Low-concentration Atropine Eye Drops Sales Value by Country (%), 2023 VS 2030
Figure 34. Middle East & Africa Low-concentration Atropine Eye Drops Sales Value, (2019-2030) & (US$ Million)
Figure 35. Middle East & Africa Low-concentration Atropine Eye Drops Sales Value by Country (%), 2023 VS 2030
Figure 36. Key Countries/Regions Low-concentration Atropine Eye Drops Sales Value (%), (2019-2030)
Figure 37. Key Countries/Regions Low-concentration Atropine Eye Drops Sales Volume (%), (2019-2030)
Figure 38. United States Low-concentration Atropine Eye Drops Sales Value, (2019-2030) & (US$ Million)
Figure 39. United States Low-concentration Atropine Eye Drops Sales Value by Type (%), 2023 VS 2030
Figure 40. United States Low-concentration Atropine Eye Drops Sales Value by Application (%), 2023 VS 2030
Figure 41. Europe Low-concentration Atropine Eye Drops Sales Value, (2019-2030) & (US$ Million)
Figure 42. Europe Low-concentration Atropine Eye Drops Sales Value by Type (%), 2023 VS 2030
Figure 43. Europe Low-concentration Atropine Eye Drops Sales Value by Application (%), 2023 VS 2030
Figure 44. China Low-concentration Atropine Eye Drops Sales Value, (2019-2030) & (US$ Million)
Figure 45. China Low-concentration Atropine Eye Drops Sales Value by Type (%), 2023 VS 2030
Figure 46. China Low-concentration Atropine Eye Drops Sales Value by Application (%), 2023 VS 2030
Figure 47. Japan Low-concentration Atropine Eye Drops Sales Value, (2019-2030) & (US$ Million)
Figure 48. Japan Low-concentration Atropine Eye Drops Sales Value by Type (%), 2023 VS 2030
Figure 49. Japan Low-concentration Atropine Eye Drops Sales Value by Application (%), 2023 VS 2030
Figure 50. South Korea Low-concentration Atropine Eye Drops Sales Value, (2019-2030) & (US$ Million)
Figure 51. South Korea Low-concentration Atropine Eye Drops Sales Value by Type (%), 2023 VS 2030
Figure 52. South Korea Low-concentration Atropine Eye Drops Sales Value by Application (%), 2023 VS 2030
Figure 53. Southeast Asia Low-concentration Atropine Eye Drops Sales Value, (2019-2030) & (US$ Million)
Figure 54. Southeast Asia Low-concentration Atropine Eye Drops Sales Value by Type (%), 2023 VS 2030
Figure 55. Southeast Asia Low-concentration Atropine Eye Drops Sales Value by Application (%), 2023 VS 2030
Figure 56. India Low-concentration Atropine Eye Drops Sales Value, (2019-2030) & (US$ Million)
Figure 57. India Low-concentration Atropine Eye Drops Sales Value by Type (%), 2023 VS 2030
Figure 58. India Low-concentration Atropine Eye Drops Sales Value by Application (%), 2023 VS 2030
Figure 59. Low-concentration Atropine Eye Drops Industrial Chain
Figure 60. Low-concentration Atropine Eye Drops Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Low-concentration Atropine Eye Drops market?
The top companies in the global Low-concentration Atropine Eye Drops market are Aspen、ENTOD Pharmaceuticals、Santen Pharmaceutical.
Related Reports
Global Low-concentration Atropine Eye Drops Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Low-concentration Atropine Eye Drops market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-31
Pages: 111
USD 4900.00
(Single User License)
Global Low-concentration Atropine Eye Drops Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Low-concentration Atropine Eye Drops market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-31
Pages: 74
USD 4250.00
(Single User License)
Low-concentration Atropine Eye Drops- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Low-concentration Atropine Eye Drops was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 90
USD 3950.00
(Single User License)
Global Low-concentration Atropine Eye Drops Market Research Report 2026
The global Low-concentration Atropine Eye Drops market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-15
Pages: 92
USD 2900.00
(Single User License)
Global Low-concentration Atropine Eye Drops Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Low-concentration Atropine Eye Drops market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 128
USD 4900.00
(Single User License)
Global Low-concentration Atropine Eye Drops Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Low-concentration Atropine Eye Drops market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 71
USD 4250.00
(Single User License)
Low-concentration Atropine Eye Drops- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Low-concentration Atropine Eye Drops was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 82
USD 3950.00
(Single User License)
Global Low-concentration Atropine Eye Drops Market Research Report 2025
The global market for Low-concentration Atropine Eye Drops was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 72
USD 2900.00
(Single User License)
Global Low-concentration Atropine Eye Drops Market Research Report 2024
Atropine eye drops have been shown safe to use in children when used as prescribed. While atropine has potential for causing toxic effects if taken by mouth, it is greatly diluted when formulated into eye drops. Medication safety is very important - if a young child accidentally swallows a bottle of atropine eye drops this can have very serious side effects.
Published Date: 2024-04-28
Pages: 75
USD 2900.00
(Single User License)
Global and United States Low-concentration Atropine Eye Drops Market Report & Forecast 2024-2030
Atropine eye drops have been shown safe to use in children when used as prescribed. While atropine has potential for causing toxic effects if taken by mouth, it is greatly diluted when formulated into eye drops. Medication safety is very important - if a young child accidentally swallows a bottle of atropine eye drops this can have very serious side effects.
Published Date: 2024-04-28
Pages: 94
USD 4350.00
(Single User License)
Global Low-concentration Atropine Eye Drops Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Low-concentration Atropine Eye Drops market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-31
Pages: 111
USD 4900.00 (Single User License)Global Low-concentration Atropine Eye Drops Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Low-concentration Atropine Eye Drops market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-31
Pages: 74
USD 4250.00 (Single User License)Low-concentration Atropine Eye Drops- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Low-concentration Atropine Eye Drops was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 90
USD 3950.00 (Single User License)Global Low-concentration Atropine Eye Drops Market Research Report 2026
The global Low-concentration Atropine Eye Drops market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-15
Pages: 92
USD 2900.00 (Single User License)Global Low-concentration Atropine Eye Drops Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Low-concentration Atropine Eye Drops market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 128
USD 4900.00 (Single User License)Global Low-concentration Atropine Eye Drops Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Low-concentration Atropine Eye Drops market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 71
USD 4250.00 (Single User License)Low-concentration Atropine Eye Drops- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Low-concentration Atropine Eye Drops was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 82
USD 3950.00 (Single User License)Global Low-concentration Atropine Eye Drops Market Research Report 2025
The global market for Low-concentration Atropine Eye Drops was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 72
USD 2900.00 (Single User License)Global Low-concentration Atropine Eye Drops Market Research Report 2024
Atropine eye drops have been shown safe to use in children when used as prescribed. While atropine has potential for causing toxic effects if taken by mouth, it is greatly diluted when formulated into eye drops. Medication safety is very important - if a young child accidentally swallows a bottle of atropine eye drops this can have very serious side effects.
Published: 2024-04-28
Pages: 75
USD 2900.00 (Single User License)Global and United States Low-concentration Atropine Eye Drops Market Report & Forecast 2024-2030
Atropine eye drops have been shown safe to use in children when used as prescribed. While atropine has potential for causing toxic effects if taken by mouth, it is greatly diluted when formulated into eye drops. Medication safety is very important - if a young child accidentally swallows a bottle of atropine eye drops this can have very serious side effects.
Published: 2024-04-28
Pages: 94
USD 4350.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now